4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Enlivex Ltd. (ENLV) operates in the Biotechnology industry and is headquartered in Ness Ziona, Israel with about 34 employees. Its market capitalization is roughly $124 million. In the fiscal year ended 2025-12-31, ENLV reported $0M in revenue and $1.2B in net income.
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($15M) | ($15M) | ($25M) | ($26M) | — |
| Net Income | $1.2B | ($15M) | ($29M) | ($31M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($6M) | ($3M) | ($3M) | ($4M) | ($5M) |
| Net Income | $1.2B | ($2M) | ($2M) | ($4M) | ($5M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $2.3B | $28M | $37M | $68M | — |
| Total Liabilities | $392M | $4M | $7M | $11M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ENLV viewer.
About TickerBase · Data methodology & sources